Product Introduction
Cefonicid Sodium is a second-generation, broad-spectrum, long-acting cephalosporin-class antibiotic. It exhibits potent activity against Haemophilus influenzae and a wide range of Enterobacteriaceae. This compound is clinically indicated for the prevention of postoperative surgical infections and the treatment of infections caused by susceptible bacteria.
Product Data Sheet
| Product name | Monocid sodium powder | Appearance | White powder |
| Specification | 99% | Molecular Formula | C18H16N6Na2O8S3 |
| Molecular Weight | 586.53 | CAS No. | 61270-78-8 |
| Density | 1.92±0.1 g/cm3(Predicted) | Storage conditions | 2-8℃ |
| Refractive index | 1.852 | Acidity coefficient | -1.23±0.50(Predicted) |
Product Function
Cefonicid Sodium is indicated for the treatment of infections due to susceptible microorganisms, including:
- Lower respiratory tract infections
- Sepsis
- Urinary tract infections
- Bone and joint infections
- Skin and soft tissue infections
- Prophylaxis of postoperative infections
Its extended half-life enables less frequent dosing, supporting improved patient compliance.
Product Side Effects
Cefonicid Sodium is generally well-tolerated. The most frequently reported adverse effect is pain upon intramuscular administration. Other possible side effects include:
- Injection site reactions: Local pain, discomfort, phlebitis, and a burning sensation at the intravenous site.
- Hematologic effects: Transient increases in platelet count and eosinophil levels.
- Hepatic abnormalities (lab findings): Elevated alkaline phosphatase, gamma-glutamyl transpeptidase (GGT), lactate dehydrogenase (LDH), and serum aminotransferases (AST/ALT).
- Allergic reactions: Fever, urticaria, rash, erythema, pruritus, myalgia, and hypersensitivity responses.
- Gastrointestinal disturbances: Nausea, diarrhea, vomiting; cases of pseudomembranous colitis have been reported.
- Hematologic suppression: Leukopenia, thrombocytopenia, neutropenia, and rare instances of hemolytic anemia.
- Renal toxicity: Sporadic reports of interstitial nephritis, elevated blood urea nitrogen (BUN), and serum creatinine; acute renal failure is rare.
- Central nervous system effects: In high-dose or CNS-susceptible patients, symptoms such as withdrawal, anxiety, and headache may occur.
- Other: Arthralgia (joint pain) and secondary Candida infections (e.g., oral or genital candidiasis).
Packaging & Delivery
FAQ
Q1: What is the recommended dosage for this product?
We advise using Cefonicid Sodium only under the guidance of a licensed healthcare provider. Please follow the prescribed dosage as directed by your physician.
Q2: Will I receive a tracking number once the order is shipped?
Yes. As soon as our logistics partner dispatches your shipment and provides the tracking details, we will share the information with you promptly.
Q3: Can I receive a Certificate of Analysis (COA) prior to delivery?
Absolutely. Please reach out to our sales manager, and we will provide the COA for your review.
Q4: Do you offer refunds if product quality does not match specifications?
Yes. If an independent third-party laboratory test (conducted under identical conditions) confirms a discrepancy with our provided test results, we accept returns and offer refunds.
For any questions or inquiries regarding Monocid Sodium, please feel free to contact us.
E-mail: [email protected]
